Aquabounty Technologies (AQB) Stock
Biotech company developing faster growing Atlantic salmon. Here's the price, business snapshot, and what's worth knowing about Aquabounty Technologies in October 2026.
Aquabounty Technologies Inc (AQB) is a micro‑cap biotechnology company that develops faster‑growing Atlantic salmon through its AquAdvantage genetic line. The commercial idea is to reduce time to market and production costs for farmed salmon, potentially improving the economics of aquaculture. With a market capitalisation around $6.28 million, AQB is small and highly speculative: shares can be volatile and liquidity is limited. The company has a notable regulatory history — including past FDA reviews — but commercial rollout has been slow and has faced operational, consumer‑acceptance and supply‑chain challenges. Potential upside exists if production scales, acceptance improves and sales grow, but risks include financing needs, regulatory changes, reputational concerns and operational setbacks. This information is educational only and not personal financial advice. Investors should carry out their own research, consider their risk tolerance and suitability, and be aware that values can rise or fall and returns are not guaranteed.
Aquabounty Technologies (AQB) Stock Forecast
Analyst price target, next 12 months
$2.00
+116.2% vs today's $0.93
Price range over the last 12 months
Close to its 12-month low
Analysts covering Aquabounty Technologies have a consensus 12-month target of $2.00, above the current price of $0.93.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 5 Jun 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying AquaBounty's stock with a target price of $2, indicating potential growth.
Financial Health
AquaBounty Technologies is maintaining a steady cash flow and book value per share, showing stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Growth Efficiency Case
AquAdvantage salmon aims to reach market size faster, which could lower unit costs if scaled; however, commercial adoption and economics remain uncertain.
Sustainable Aquaculture
Genetic improvements may support more efficient farming and reduced resource use, though consumer acceptance and regulation could limit market access.
Regulatory Watch
Past regulatory milestones matter for sales and exports; any future approvals or restrictions will materially affect prospects, and the small market cap adds risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
